1. Home
  2. GRFS vs BBWI Comparison

GRFS vs BBWI Comparison

Compare GRFS & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • BBWI
  • Stock Information
  • Founded
  • GRFS 1940
  • BBWI 1963
  • Country
  • GRFS Spain
  • BBWI United States
  • Employees
  • GRFS N/A
  • BBWI N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • BBWI Clothing/Shoe/Accessory Stores
  • Sector
  • GRFS Health Care
  • BBWI Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • BBWI Nasdaq
  • Market Cap
  • GRFS 5.9B
  • BBWI 5.0B
  • IPO Year
  • GRFS 2006
  • BBWI N/A
  • Fundamental
  • Price
  • GRFS $8.39
  • BBWI $16.24
  • Analyst Decision
  • GRFS Hold
  • BBWI Buy
  • Analyst Count
  • GRFS 1
  • BBWI 18
  • Target Price
  • GRFS $10.30
  • BBWI $28.28
  • AVG Volume (30 Days)
  • GRFS 779.1K
  • BBWI 10.0M
  • Earning Date
  • GRFS 01-01-0001
  • BBWI 11-20-2025
  • Dividend Yield
  • GRFS 1.70%
  • BBWI 5.14%
  • EPS Growth
  • GRFS N/A
  • BBWI N/A
  • EPS
  • GRFS 0.64
  • BBWI 3.30
  • Revenue
  • GRFS $8,821,017,248.00
  • BBWI $7,354,000,000.00
  • Revenue This Year
  • GRFS $5.31
  • BBWI $4.09
  • Revenue Next Year
  • GRFS $6.02
  • BBWI $2.75
  • P/E Ratio
  • GRFS $16.23
  • BBWI $4.72
  • Revenue Growth
  • GRFS 7.31
  • BBWI N/A
  • 52 Week Low
  • GRFS $6.19
  • BBWI $14.28
  • 52 Week High
  • GRFS $11.14
  • BBWI $41.87
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 33.65
  • BBWI 22.03
  • Support Level
  • GRFS $8.33
  • BBWI $14.28
  • Resistance Level
  • GRFS $8.64
  • BBWI $22.43
  • Average True Range (ATR)
  • GRFS 0.21
  • BBWI 0.80
  • MACD
  • GRFS -0.00
  • BBWI -0.67
  • Stochastic Oscillator
  • GRFS 26.21
  • BBWI 18.68

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like hair and laundry.

Share on Social Networks: